Fahim Shahriar

Two new drugs have been approved by the who, protecting covid-19. As the more infectious Omicron version of the coronavirus causes an unprecedented spike in cases around the world, the WHO has authorized two new medications as recommended treatments for COVID-19. Young children and babies are more likely to be impacted by the Omicron variation than older people, according to British experts, although the problem is still under control. In addition to corticosteroids, the medicine baricitinib, which is also used to treat arthritis, is "highly advised" for individuals with severe or critical COVID-19. The panel additionally gave "sotrovimab," an investigational antibody therapy whose Omicron variant is increasing at an alarming rate, a "conditional recommendation."As a result, China, Hong Kong, the United Kingdom, and the United States are thought to be taking the most likely measures to safeguard the lives of their citizens. Last week, the WHO received an alarming number of COVID-19 cases — by far the most in a single week – due to the Omicron variation, which has been replaced by the delta variant. To deal with this variation, we should all be aware, wear masks, and maintain social distance during social interactions.